TNF-α in promotion and progression of cancer

被引:758
作者
Balkwill, Frances [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, Ctr Translat Oncol, Inst Canc, John Vane Sci Ctr, London EC1M 6BQ, England
基金
英国医学研究理事会;
关键词
TNF-alpha; inflammation; cytokine; chemokine;
D O I
10.1007/s10555-006-9005-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour necrosis factor alpha is a member of the TNF/TNFR cytokine superfamily. In common with other family members, TNF-alpha is involved in maintenance and homeostasis of the immune system, inflammation and host defence. However, there is a 'dark side' to this powerful cytokine; it is now clear that, especially in middle and old age, TNF-alpha is involved in pathological processes such as chronic inflammation, autoimmunity and, in apparent contradiction to its name, malignant disease. This article will discuss the involvement of TNF-alpha in the inflammatory network that contributes to all stages of the malignant process, and consider the possibility that TNF-alpha may be a target for cancer therapy.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 71 条
[31]   Novel tumor necrosis factor-knockout mice that lack Peyer's patches [J].
Kuprash, DV ;
Tumanov, AV ;
Liepinsh, DJ ;
Koroleva, EP ;
Drutskaya, MS ;
Kruglov, AA ;
Shakhov, AN ;
Southon, E ;
Murphy, WJ ;
Tessarollo, L ;
Grivennikov, SL ;
Nedospasov, SA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1592-1600
[32]   Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma [J].
Kyriakou, C ;
Thomson, K ;
D'Sa, S ;
Flory, A ;
Hanslip, J ;
Goldstone, AH ;
Yong, KL .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) :763-770
[33]   Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability [J].
Lejeune, FJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :433-435
[34]   The TNF and TNF receptor superfamilies: Integrating mammalian biology [J].
Locksley, RM ;
Killeen, N ;
Lenardo, MJ .
CELL, 2001, 104 (04) :487-501
[35]  
Lu T, 2004, CELL CYCLE, V3, P1114
[36]   Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression [J].
Luo, JL ;
Maeda, S ;
Hsu, LC ;
Yagita, H ;
Karin, M .
CANCER CELL, 2004, 6 (03) :297-305
[37]   A phase II study of etanercept (enbrel), a tumor necrosis factor α inhibitor in patients with metastatic breast cancer [J].
Madhusudan, S ;
Foster, M ;
Muthuramalingam, SR ;
Braybrooke, JP ;
Wilner, S ;
Kaur, K ;
Han, C ;
Hoare, S ;
Balkwill, F ;
Talbot, DC ;
Ganesan, TS ;
Harris, AL .
CLINICAL CANCER RESEARCH, 2004, 10 (19) :6528-6534
[38]  
MADHUSUDAN S, 2005, J CLIN ONCOL, V10, P6528
[39]   IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis [J].
Maeda, S ;
Kamata, H ;
Luo, JL ;
Leffert, H ;
Karin, M .
CELL, 2005, 121 (07) :977-990
[40]   CELLS SECRETING TUMOR-NECROSIS-FACTOR SHOW ENHANCED METASTASIS IN NUDE-MICE [J].
MALIK, STA ;
NAYLOR, MS ;
EAST, N ;
OLIFF, A ;
BALKWILL, FR .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (10) :1031-1034